The fate of 17 beta-estradiol in the plasma of premenopausal and postmenopausal patients with cancer.
The patterns of radioactive estrogen metabolities in the plasma of patients with a variety of malignancies were determined after the injection of physiological amounts of 17 beta-estradiol-6,7-3H or of estrone-6,7-3H. The metabolites were separated and isolated from the plasma by the following procedures: a) alumina chromatography, b) modified Brown procedure, and c) gas liquid chromatography. This study showed that the conjugated state of the estrogens varied with the subjects's age. There was a dramatic decrease in the relative quantity of the plasma free estrogens which are converted to sulfates as the age of the patient increased. This change was noted just prior to menopause, suggesting that there are alterations in the conjugation of plasma estrogens which are detectable before clinical menopause.
D000230:Adenocarcinoma / Q000097:blood; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001943:Breast Neoplasms / Q000097:blood; D002277:Carcinoma / Q000097:blood; D004958:Estradiol / Q000008:administration & dosage / Q000097:blood*; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood*; D010051:Ovarian Neoplasms / Q000097:blood; D013431:Sulfates / Q000378:metabolism
D004967:Estrogens; D013431:Sulfates; D004958:Estradiol